Simulations Plus (NASDAQ:SLP) Receives Outperform Rating from William Blair

Simulations Plus (NASDAQ:SLP)‘s stock had its “outperform” rating reiterated by research analysts at William Blair in a research report issued on Wednesday,RTT News reports.

A number of other equities analysts have also recently weighed in on SLP. BTIG Research reduced their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. Stephens started coverage on Simulations Plus in a research note on Friday, November 15th. They issued an “overweight” rating and a $39.00 price target on the stock. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $51.40.

Simulations Plus Trading Down 16.7 %

NASDAQ SLP traded down $5.07 on Wednesday, hitting $25.32. 394,285 shares of the company’s stock traded hands, compared to its average volume of 320,626. The firm has a market capitalization of $508.55 million, a PE ratio of 51.67 and a beta of 0.80. Simulations Plus has a 1-year low of $24.00 and a 1-year high of $51.22. The firm’s 50-day moving average price is $29.78 and its two-hundred day moving average price is $34.16.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company’s revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the business posted $0.18 EPS. On average, research analysts anticipate that Simulations Plus will post 1.1 earnings per share for the current fiscal year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $31.76, for a total value of $635,200.00. Following the sale, the director now owns 3,442,584 shares in the company, valued at $109,336,467.84. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 19.40% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of SLP. Tributary Capital Management LLC lifted its stake in Simulations Plus by 54.7% during the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after acquiring an additional 115,122 shares in the last quarter. Royce & Associates LP boosted its position in Simulations Plus by 28.8% in the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after buying an additional 53,092 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Simulations Plus by 10.1% in the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after acquiring an additional 37,992 shares in the last quarter. Congress Asset Management Co. increased its position in shares of Simulations Plus by 22.5% during the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after acquiring an additional 37,914 shares during the period. Finally, BNP Paribas Financial Markets raised its stake in shares of Simulations Plus by 402.9% in the third quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock valued at $1,279,000 after acquiring an additional 32,002 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.